Merrimack Pharmaceuticals, Inc.

NasdaqGM:MACK Stock Report

Market Cap: US$214.2m

Merrimack Pharmaceuticals Dividend

Dividend criteria checks 0/6

Merrimack Pharmaceuticals does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.081
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

We're Not Worried About Merrimack Pharmaceuticals' (NASDAQ:MACK) Cash Burn

Feb 14
We're Not Worried About Merrimack Pharmaceuticals' (NASDAQ:MACK) Cash Burn

Companies Like Merrimack Pharmaceuticals (NASDAQ:MACK) Are In A Position To Invest In Growth

Sep 23
Companies Like Merrimack Pharmaceuticals (NASDAQ:MACK) Are In A Position To Invest In Growth

Merrimack Pharmaceuticals GAAP EPS of -$0.04

Aug 04

Here's Why We're Not At All Concerned With Merrimack Pharmaceuticals' (NASDAQ:MACK) Cash Burn Situation

Mar 19
Here's Why We're Not At All Concerned With Merrimack Pharmaceuticals' (NASDAQ:MACK) Cash Burn Situation

We're Interested To See How Merrimack Pharmaceuticals (NASDAQ:MACK) Uses Its Cash Hoard To Grow

May 19
We're Interested To See How Merrimack Pharmaceuticals (NASDAQ:MACK) Uses Its Cash Hoard To Grow

Are Insiders Selling Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Stock?

Feb 22
Are Insiders Selling Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Stock?

Merrimack Pharmaceuticals (NASDAQ:MACK) Is In A Strong Position To Grow Its Business

Jan 01
Merrimack Pharmaceuticals (NASDAQ:MACK) Is In A Strong Position To Grow Its Business

Merrimack Pharma jumps 42% on bullish timeline for potential Onivyde milestone payment

Dec 02

Merrimack Pharmaceuticals reports Q3 results

Nov 05

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if MACK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MACK's dividend payments have been increasing.


Dividend Yield vs Market

Merrimack Pharmaceuticals Dividend Yield vs Market
How does MACK dividend yield compare to the market?
SegmentDividend Yield
Company (MACK)n/a
Market Bottom 25% (US)1.6%
Market Top 25% (US)4.8%
Industry Average (Biotechs)2.9%
Analyst forecast in 3 Years (MACK)n/a

Notable Dividend: Unable to evaluate MACK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MACK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate MACK's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MACK has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.